Chapter 31: Quinolones, Folic Acid Antagonists, and Urinary Tract Antiseptics

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Imagine turning a patient's own bladder into a literal chemical weapons factory.

Right.

No complex enzymes or targeted genetic warfare.

Exactly.

Just taking advantage of human waste systems to generate raw like 19th century formaldehyde right where the infection actually lives.

It's incredible.

It really is.

So welcome to another deep dive.

Today we're tackling Chapter 31 of Lippincott Illustrated Reviews, Pharmacology.

Yes, looking at quinolones, folic acid antagonists, and urinary tract antiseptics.

So if you are a student staring down this material, you know, trying to make sense of all these drug classes, you are in exactly the right place.

Consider this a highly targeted session coming directly to you from the Last Minute Lecture team.

It's a fascinating chapter.

It honestly reads like a history of a biological arms race.

Yeah.

How researchers developed these absolute wonder drugs and then how bacteria just brilliantly mutated their own architecture to fight back.

Right.

And how sometimes, you know, the most effective way to win the war is to completely abandon modern targeted therapies.

And just rely on ancient blunt force chemistry.

I love that.

So our mission today is to walk through the material exactly as it's laid out in the text.

Starting with the fluoroquinolones, then moving to the folate antagonists, and finishing up with those localized urinary tract antiseptics.

Connecting the foundational physiology straight to the clinical application.

So let's start with the heavy hitters, the fluoroquinolones.

Yeah, these were historically massive.

Right.

If you look at the history, they were prescribed for practically everything not too long ago.

But reading the text, it's clear they've suffered this huge fall from grace.

Oh, absolutely.

They are heavily restricted now.

But before we get into the why, like why they are suddenly relegated to second line auctions, I really need to understand how they work.

The text says they cause permanent chromosomal breaks.

Yes.

If a drug is literally shattering DNA, how is it doing that?

Well, to understand that, we have to look at how bacteria replicate their DNA in the first place.

Bacteria DNA is incredibly long, right?

And it's tightly coiled up inside the cell just to save space.

So when the bacteria want to multiply, they have to unwind that DNA so it can be copied.

Okay, I'm trying to visualize this.

Is it kind of like, like trying to pull apart a really tightly twisted, incredibly long zipper on a jacket?

That is a perfect analogy.

Because if I just grab the two sides of that zipper and pull them apart without untwisting the fabric first, the tension down the line just builds and builds.

And eventually, you know, the zipper jams or the teeth just snap off entirely.

And that is the exact mechanical problem the bacteria face.

It's literally called torsional stress.

Wow.

If they just pull the DNA strands apart, the tension ahead of the split becomes so immense that the DNA molecule would physically break.

So how do they not just explode every time they divide?

They use specific enzymes to manage it.

These are called type two to poissamerases.

They constantly manage that tension.

By doing what?

They essentially cut the DNA, relieve that physical twisting pressure, and then perfectly glue the strands back together.

Okay, so in the textbook, they give specific names for these enzymes, right?

Yes.

In Gram -negative bacteria, the main enzyme doing this is called DNA gyrase.

DNA gyrase, okay.

And in Gram -positive bacteria, a slightly different enzyme called topoisomerase, 4, handles a really similar job, specifically helping to separate the newly copied chromosomes.

So the bacteria have their own built -in tension relief system.

Where do the fluoroquinolones come into the picture?

Do they just destroy the enzyme?

Not exactly.

They enter the bacterial cell through these porin channels in the outer membrane.

Okay.

And once inside, they find those specific enzymes, DNA gyrase or topoisomerase 4, and they bind to them right at the exact moment the enzyme has cut the DNA.

Oh, wow.

Yeah.

They don't destroy the enzyme.

They basically freeze it.

They block the relegation step.

So the DNA has been cut to alleviate the tension, but the fluoroquinolone stops the enzyme from sealing it back up.

Precisely.

So the zipper is cut, and the drug just hides the glue.

That's exactly it.

And because these enzymes are actively working all over the bacterial chromosome during replication,

the introduction of a fluoroquinolone suddenly results in permanent chromosomal breaks everywhere.

Just a total structural collapse.

The bacterial DNA shatters.

And when a cell's blueprint is fragmented like that, it triggers rapid cell lysis.

The bacteria just physically break apart and die.

Right.

And because they kill the bacteria outright, rather than just slowing their growth down, fluoroquinolones are classified as bactericidal.

Okay.

That makes total sense as a mechanism, but the text breaks these drugs down into multiple generations.

Yes, four generations.

Right.

We've got first, second, third, and fourth generation quinolones.

If shattering the DNA works so perfectly, why did chemists need to keep changing the chemical structure over the decades?

Well, it comes down to the natural defenses of different types of bacteria.

The very first generation drugs like naladixic acid had a very narrow spectrum.

Like they couldn't get into certain bugs.

Exactly.

They were really only effective against aerobic gram -negative bacilli, specifically a group called the enterobacteriaceae.

So useful for basic UTIs, but not much else.

Right.

But chemists realized that if they tweaked the central ring structure of the drug specifically by adding a fluorine atom.

Oh, which is why we call them fluoroquinolones.

Exactly.

Adding the fluorine allowed them to trick the defenses of entirely different classes of bacteria.

So they were basically picking the lock to get the drug inside a wider variety of targets.

That's the idea.

So by modifying the molecule, the second generation emerged, and that is headlined by ciproxacin.

Cipro, right.

Really common.

Very common.

Cipro kept the ability to fight the standard gram -negative bugs, but drastically expanded its reach.

Suddenly, it could penetrate Pseudomonas aeruginosa.

Which is notoriously difficult to treat, right?

Incredibly difficult.

Yeah.

And it could also target atypical organisms that don't have standard cell walls, like the bacteria that cause chlamydia and legionella.

And I'm assuming the third generation pushed that boundary even further.

It did.

The third generation, which is represented by levofloxacin, was engineered to maintain that gram -negative coverage while vastly improving its ability to kill tough gram -positive bacteria.

Like what?

Specifically, it became highly active against streptococcus pneumonia, which is a major cause of severe respiratory infections.

Okay, so we're covering more and more ground.

Right.

And finally, the fourth generation compounds, like moxafloxacin and delafloxacin, pushed the limits again.

What did they add?

Moxafloxacin brings in strong activity against anaerobic bacteria, you know, the bugs that thrive without oxygen.

And delafloxacin is a huge standout because it maintains activity against Pseudomonas while simultaneously being able to kill MRSA.

Wait, methicillin -resistant Staphylococcus aureus.

Yes.

Wow!

Okay.

I want to pivot to how these drugs actually behave in the human body because there is a chart in the text here, figure 31 .4, and I'm honestly a bit lost looking at it.

The yogurt graph.

Yeah.

It tracks the concentration of a single 500 -milligram dose of ciprofloxacin in a patient's blood over 24 hours.

Right.

When they take the pill with a glass of water, there is this massive, beautiful spike in the drug's concentration.

A perfect absorption curve.

But on the exact same graph, if they take that pill with a cup of yogurt, that massive peak completely vanishes.

It just becomes this tiny little bump.

How does a cup of yogurt destroy an antibiotic?

It's an incredibly important pharmacokinetic trap.

Fluoroquinolones have a chemical tendency to undergo something called chelation.

Chelation.

What does that mean physically?

They bind very aggressively to divalentications.

Which are?

Essentially metal ions floating around with a plus -two electrical charge.

Calcium, which is heavily concentrated in milk, yogurt, and cheese, is a primary culprit.

Ah, okay.

But the drug will also eagerly bind to zinc, magnesium, and iron, which are common in over -the -counter antacids and standard dietary supplements.

So if I swallow a Cipro pill and then eat some yogurt, the drug and the calcium meat in my stomach, what actually happens?

They lock together and form a massive insoluble chemical complex.

The human digestive tract is designed to absorb specific bioavailable molecules.

It simply cannot absorb this bulky, chelated mass.

So it's just stuck there.

Right.

It gets trapped in the gut and passes right through your digestive system without ever entering your bloodstream.

So the infection remains completely untreated.

So strict dietary counseling, making sure patients don't take these drugs alongside dairy or antacids, is a mandatory clinical consideration.

That is a massive clinical pearl.

Now, assuming the drug is absorbed properly and you skip the yogurt, how does the body eventually get rid of it?

Because the text makes a huge point about elimination when it comes to treating UTIs.

The elimination route determines what infections the drug can actually cure.

The vast majority of fluoroquinolones,

including ciprofloxacin and levofloxacin, are excreted by the kidneys entirely unchanged.

Meaning they don't get broken down first.

Right.

So as the kidneys filter the blood, they dump massive active concentrations of the drug directly into the urine.

That makes them highly effective at sterilizing the bladder.

Exactly.

Great for complicated UTIs.

But the textbook highlights one critical, dangerous exception,

moxifloxacin.

The fourth generation one.

The notes say moxifloxacin is hepatically metabolized.

It's cleared by the liver.

Because the liver processes moxifloxacin and clears it through the biliary system, the active drug never concentrates in the urine.

So if a doctor mistakenly prescribes moxifloxacin for a UTI...

The treatment will completely fail because the weapon never actually reaches the battlefield.

Okay.

So we have drugs that can shatter bacterial DNA, cover everything from pseudomonas to MRSA, and if you avoid the dairy, they absorb incredibly well.

They do.

Why on earth are the guidelines now restricting them to second -line therapies?

If they work so well, why aren't we just using them first?

And because the collateral damage to the human body can be devastating.

These drugs carry multiple severe boxed warnings from the FDA.

Boxed warnings are the most serious ones, right?

The highest level of warning.

The most notorious is the risk of tendonitis and spontaneous tendon rupture.

Yeah, the textbook actually features a clinical vignette describing a 21 -year -old marathon runner.

Right, who develops an acute Achilles tendon rupture while taking levofloxacin for pneumonia.

That's terrifying.

It is.

This isn't just a vague side effect.

It is a highly specific structural damage to human connective tissue, and that risk is amplified if the patient is older or taking corticosteroids.

And the warnings don't stop at tendons either.

No.

They also carry boxed warnings for peripheral neuropathy, which is nerve damage in the extremities and severe central nervous system effects.

Like what?

Everything from severe dizziness to hallucinations, confusion, and in extreme cases, active seizures.

I'm also seeing phototoxicity on this list.

Yes.

Patients can apparently get exaggerated, blistering sunburns from completely normal sun exposure while taking these, so heavy sunscreen is required.

That's right.

And then there's QT prolongation, which means the drug can alter the electrical cycle of the heart, risking dangerous arrhythmias.

It's a very long list of severe risks.

Plus, the text notes that ciprofloxacin specifically inhibits liver enzymes, CYP450, 1A2, and 3A4.

And that liver enzyme inhibition is a silent killer in pharmacology.

How so?

Well, if a patient is taking a drug that relies on those specific enzymes to be cleared from your body, like the blood thinner warfarin or the asthma drug theofiline, and you're given ciprofloxacin.

The cipro blocks the exit door.

Exactly.

The warfarin builds up in the blood to toxic levels, drastically increasing the risk of a major hemorrhage.

Wow.

So if breaking the bacterial zipper comes with the risk of snapping human tendons and triggering seizures,

how else can we attack these bugs?

We have to look at different targets.

What if instead of destroying the DNA zipper after it's built, we just starve the bacteria of the raw materials they need to build it in the first place?

That is precisely the logic behind the next major class in the chapter, the folate antagonists.

It's a completely different philosophical approach.

It really is.

Folic acid is the ultimate biological building block.

Every living cell needs it to synthesize RNA, DNA, and amino acids.

Without folate, a cell cannot divide.

Okay.

Now, humans are quite lucky.

We can just order our folate in, we absorb it directly from the food we eat, but bacteria have a fatal biological flaw.

They're entirely impermeable to environmental tolpolic acid.

Meaning even if a bacteria is swimming in a pool of folic acid, it can't absorb a single molecule of it.

Correct.

So to survive, bacteria have to manufacture their own active folate from scratch.

Using a cellular assembly line.

Yes.

And that assembly line is the sole target of these drugs.

The text lays out this assembly line step by step.

We'll walk through the physiology so we can understand the sabotage.

Where does the bacteria start?

It starts with a base chemical precursor called paeba -paraminobenzoic acid.

Okay.

Paeba.

The bacteria has a specific enzyme called dihydroptorate synthetase to grab that paeba and convert it into the next molecule in line, which is dihydrofolic acid.

That is step one.

And this is where the first group of drugs in the section comes in.

The sulfonamides.

The sulfa drugs.

Looking at their chemical structure, I like to think of them as imposters.

That is the perfect way to describe competitive inhibition.

Because they look like paeba.

Exactly.

Sulfonamides, like sulfamazoxazole, are structural lookalikes of paeba.

They mimic its shape so perfectly that the bacterial enzyme gets confused.

Oh, wow.

When the enzyme reaches out to grab paeba to start making folate, it accidentally grabs the sulfa drug instead.

So the drug just jams the enzyme.

Yes.

The assembly line grinds to a complete halt and the bacteria stop producing dihydrofolic acid.

But unlike the cunnolones that shatter the DNA and just explode the cell, just stopping the assembly line doesn't immediately kill the bacteria, right?

Right.

It just starves them.

It stops them from growing and dividing.

So the immune system still has to come in and finish the job.

Exactly.

Because they only pause bacterial growth, sulfonamides are classified as bacteriostatic, not bactericidal.

That makes sense.

But the human body still has to process these imposter drugs, and the text mentions a really dangerous issue with how they exit the body through the urine.

Something called crystalluria.

Yeah, this is a big one.

When sulfur drugs pass through the liver,

the human body attempts to neutralize them through a process called acetylation.

This acetylated version of the drug no longer has any antibacterial power, but it gains a very dangerous physical property.

It becomes highly insoluble in neutral or acidic environments.

Oh, and urine is naturally acidic.

Exactly.

As the kidneys filter this metabolite into the urine, the drug precipitates.

It literally drops out a solution and forms microscopic, jagged solid crystals in the urinary tract.

So the patient is essentially forming sharp, drug -induced kidney stones.

Yes, and it can cause severe tearing and damage to the kidneys and ureters.

How do you stop that?

Patients taking high doses of sulfur drugs must stay incredibly well hydrated to constantly flush the system.

And sometimes physicians even have to alkalinize the patient's urine to keep the drug dissolved.

There's also a massive, brightly highlighted contraindication here regarding newborns.

The text says sulfur drugs are strictly forbidden in infants under two months of age and in pregnant women near term.

Why are they so dangerous for babies?

It involves how the drug travels in the blood.

Sulfur drugs bind very strongly to a protein in human blood called serum algumin.

Okay.

The problem is newborns naturally have a lot of bilirubin, which is a byproduct of breaking down red blood cells that is also trying to bind to that exact same algumin to be safely carried away.

And the sulfur drug just fights it for the smart.

No, the sulfur drug is stronger.

It aggressively kicks the bilirubin off the algumin.

It displaces it.

Yes.

So suddenly you have a surge of free -floating bilirubin in the newborn's blood.

In adults, this would be catastrophic.

Because our brains are protected.

But a newborn's blood -brain barrier is not fully developed.

That toxic free bilirubin crosses directly into the central nervous system and deposits in the basal ganglia of the brain,

causing a fatal, irreversible form of brain damage called kernictris.

Wow.

It's a tragic interaction, which is why sulfur drugs are absolutely contraindicated in that population.

Okay.

So sulfonamides block step one of the bacterial assembly line by impersonating pava.

But the bacteria have a step two.

Once they make dihydrophilic acid, the job isn't done.

Enter the next drug, trimethoprim.

Right.

If a bacteria manages to synthesize dihydrophilic acid, it's still useless.

It has to be converted into its metabolically active form called tetrahydrophilic acid.

Okay.

The bacteria use a completely different enzyme for this second step, dihydrophilic reductase.

Trimethoprim is a drug designed to target and inhibit that specific enzyme,

completely blocking the final conversion.

But wait a minute.

You mentioned earlier that humans absorb our folate from our diet.

Yes.

But we still have to convert that dietary folate into its active form, right?

So human cells possess dihydropholate reductase too.

We do.

If trimethoprim attacks that enzyme, why doesn't it just shut down my own cellular assembly line and starve the human host?

That is the core challenge of pharmacology, right?

Selective toxicity.

How do we kill the invader without killing the host?

The answer here is selective affinity.

While both humans and bacteria use a version of dihydropholate reductase,

the physical shape of the enzyme is slightly different between the two species.

Okay, so they aren't identical.

Right.

Trimethoprim has an incredibly high affinity for the bacterial version.

It binds to the bacterial enzyme tens of thousands of times more strongly than it binds to the human version.

So it selectively starves the pathogen while effectively ignoring human cells.

Exactly.

It's incredible engineering.

But I imagine it's not totally without risk to the patient.

No, it isn't.

In healthy patients, the human enzyme functions fine.

But in patients who are already running low on folate, like pregnant patients or those suffering from malnutrition or alcoholism… That tiny bit of human enzyme inhibition is enough to cause problems.

Yes.

It can tip them over the edge.

It can induce a state of severe folic acid deficiency, leading to megalblastic anemia.

Where the body starts producing massive dysfunctional red blood cells.

Right.

Can we fix that if it happens?

Yes, by administering flenic acid, which is also known as leucovorin.

Leucovorin.

Humans can readily absorb and use leucovrin to bypass the blocked enzyme and resume making blood cells.

But bacteria cannot absorb it, so the infection remains starved.

That's brilliant.

It's also worth noting that trimethoprim acts a bit like a potassium -sparing diuretic in the kidneys, meaning it can cause hyperkalemia, dangerously elevated potassium levels in the blood.

Okay, so we have sulfa drugs blocking step one and trimethoprim blocking step two.

The text brings these together in what looks like a masterclass of synergistic pharmacology.

Yes.

A drug combination called cotrimoxazole.

Cotrimoxazole is simply the combination of sulfamethoxazole and trimethoprim formulated into a single pill.

There's a fascinating chart here, figure 31 .10, that proves why this is so necessary.

It tracks the growth of an E.

coli culture over 10 hours.

I love this graph.

When you just leave the bacteria alone, the line skyrockets as they multiply into the thousands.

Obviously.

If you apply just trimethoprim or just sulfamethoxazole, the line slows down, but it still steadily creeps upward over time.

The single drugs are bacteriostatic, they just slow the bugs down.

But when you apply the combined cotrimoxazole, the line instantly flatlines.

Blocking one step of the assembly line slows production.

Blocking two sequential steps simultaneously causes a catastrophic metabolic collapse in the bacteria.

So it kills them.

Yes.

The combination transforms two merely bacteriostatic drugs into a bactericidal powerhouse.

They achieve a synergistic effect that is far greater than the sum of their parts.

And what does that mean clinically?

Where do we actually use this powerhouse?

It gives cotrimoxazole an incredibly broad and vital spectrum.

It's highly effective for urinary tract infections.

But its unique mechanism makes it the absolute standard of care for a few severe specialized infections.

It's the drug of choice for treating and preventing pneumocystis girovaceae pneumonia.

Which is common in immunocompromised patients, right?

Specifically, life -threatening opportunistic fungal infections in patients with HIV.

It's also highly effective against nocardia infections.

And impressively, it is a primary oral option for treating community -acquired MRSA skin and soft tissue infections.

We keep mentioning urinary tract infections.

Quinolones were the standard, but they break tendons.

Right.

Cotrimoxazole is great, but resistance is climbing.

Yes, unfortunately.

The text notes that because common bugs like E.

coli have mutated to outsmart these systemic whole -body antibiotics, the medical field is increasingly turning back to older localized drugs.

Drugs that act exclusively in the bladder itself.

Yes, the urinary tract antiseptics.

And reading about the first one, methamamine, I honestly had to read the paragraph twice.

It doesn't function like a traditional antibiotic at all.

No, it doesn't rely on jamming enzymes or starving assembly lines.

Methamamine is a brilliant chemical weapon delivery system.

Delivery system.

When a patient swallows a methamamine pill, it circulates through their bloodstream as a completely dormant, inactive salt.

It doesn't interact with human cells or bacterial enzymes at all.

So how does it kill anything?

Its mechanism, shown beautifully in figure 31 .14, is entirely dependent on the physical pH of its environment.

When this dormant salt is filtered out of the blood by the kidneys and sits in the bladder,

it encounters urine.

If that urine is acidic enough, specifically a pH of 5 .5 or lower,

the methamamine undergoes a rapid chemical degradation process called hydrolysis.

And what does it break into?

Right there in the bladder, the salt physically breaks apart into two distinct compounds.

Ammonia and formaldehyde.

Formaldehyde.

The exact same chemical used in embalming fluid.

The patient's bladder just manufactures raw formaldehyde.

Exactly.

And formaldehyde doesn't care about bacterial enzymes or DNA replication cycles.

It is a highly toxic, volatile chemical that aggressively denatures the proteins and nucleic acids of any bacteria it touches.

Causing immediate cell death.

Instantly.

The brilliance of this really hits when you think about the arms race we started with.

Bacteria are constantly mutating.

They change their DNA gyrase to survive Cipro.

They alter their enzymes to survive sulfid drugs.

But a bacteria cannot mutate to become resistant to a pool of raw formaldehyde.

It's impossible.

It's a fundamentally foolproof chemical environment.

And that lack of resistance is its primary clinical value.

Because it doesn't select for resistant superbugs, methamphetamine is used extensively as a chronic suppressive therapy.

So for people who just get UTI after UTI.

Exactly.

If a patient suffers from constant recurring UTIs, they can take methamphetamine long term to simply maintain a hostile formaldehyde -rich environment in the bladder to prevent infections from ever taking root.

Are there patients who shouldn't use it?

Yes.

Because the hydrolysis process generates ammonia alongside the formaldehyde, it is strictly contraindicated in patients with hepatic failure.

Because the liver can't handle the ammonia.

A healthy liver can clear that ammonia, but a failing liver cannot, leading to severe neurological toxicity.

Makes sense.

And, tying back to our previous discussion, you must never give methamphetamine to a patient who is currently taking sulfonamides.

Oh wait, why?

The sulfur drugs will physically react with the newly generated formaldehyde in the bladder,

forming a cement -like crystalline structure in the urine.

Oh wow.

Definitely want to keep those prescriptions far apart.

Very far apart.

The chapter finishes up with one more localized defender,

nitroferrantone.

Ah, nitroferrantone.

This is an old school drug from the 1950s that has experienced a massive resurgence due to modern bacterial resistance.

How does it work?

Inside the bacteria, it gets reduced by bacterial enzymes into highly reactive intermediates that physically attack and inhibit DNA and RNA synthesis.

Today,

it is widely considered the first -line therapy for uncomplicated cystitis, or standard bladder infections.

It concentrates beautifully in the urine and is generally very well tolerated.

But the textbook provides a really important clinical vignette as a warning here.

It describes an assessment of a 70 -year -old woman presenting with a UTI.

She has a history of hypertension and, crucially,

chronic kidney disease.

That vignette highlights the single most important rule regarding nitroferrantone.

It must never be used in patients with significantly impaired renal function.

Because it needs the kidneys to get to the bladder.

The entire mechanism relies on the kidneys filtering the drug out of the blood and dumping it into the bladder.

If the kidneys are failing, two disastrous things happen.

First being that the drug never reaches the bladder, so the UTI goes completely untreated.

Right.

And second, because it can't be excreted, the drug builds up systemically in the blood, leading to severe, dangerous toxicity in the patient.

So for that 70 -year -old woman with chronic kidney disease, you must pivot to an alternative agent.

Absolutely.

The text also notes that even in healthy patients, if nitroferrantone is used for prolonged periods, say greater than a month for suppression, it can trigger rare but incredibly severe adverse events.

Yes.

The most terrifying being irreversible pulmonary fibrosis where the lungs actually become scarred and stiff.

Wow.

From tendon ruptures to conicteris to pulmonary fibrosis, these drugs demand immense respect and careful patient selection.

They absolutely do.

So, as we close the book on Chapter 31, let's look at where we've been.

We started with the floriconolones, brilliantly designed to shatter bacterial DNA but restricted by severe collateral damage to human connective tissue and nerves.

Right.

Then we explored the folate antagonists, the sulfide drugs, and trimethoprim, working together as a synergistic team to competitively starve the bacterial assembly line.

And finally, we traveled down to the localized defenses of the bladder.

Utilizing old -school chemical reactions like methamphetamine to bypass modern bacterial resistance entirely.

It leaves us with an incredibly fascinating dynamic to consider.

Bacteria are endlessly brilliant at mutating, to outsmart our most complex, highly engineered targeted therapies.

Yeah, they can subtly alter the shape of their DNA gyrase to survive ciprofloxacin.

Yet these same highly evolved superbugs are completely defenseless against the simple blunt force 19th century chemical reaction like methamphetamine turning into formaldehyde and slightly acidic urine.

It's kind of poetic.

As we face a future dominated by widespread antibiotic resistance, perhaps the solution isn't always building infinitely more complex, targeted molecules.

Perhaps the future of infectious disease is finding clever new ways to deliver simple ancient chemistry locally to exactly where the bacteria live.

That is a phenomenal thought to mull over before your exam.

On behalf of the last minute lecture team, thank you so much for joining us and studying with us today.

We wish you the absolute best of luck on your pharmacology journey and remember, keep those assembly lines running smoothly.